Feng Tian is the founder of Ambrx. He leads the company in developing Engineered Precision Biologics using an expanded genetic code technology platform.
Feng Tian is the Co-founder, Chief Executive Officer, and Chairman of the Board of Ambrx Biopharma Inc., a clinical-stage biopharmaceutical company. He leads the company in developing Engineered Precision Biologics using an expanded genetic code technology platform.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide